Atreca, Inc. EPS Growth (diluted)

EPS Growth (diluted) of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS Growth (diluted) growth rates and interactive chart. Year over year growth in diluted earnings per share.


Highlights and Quick Summary

  • EPS Growth (diluted) for the quarter ending September 30, 2022 was 18.92% (a Infinity% increase compared to previous quarter)
  • Year-over-year quarterly EPS Growth (diluted) decreased by -174.49%
  • Annual EPS Growth (diluted) for 2021 was -9.26% (a -125.29% decrease from previous year)
  • Annual EPS Growth (diluted) for 2020 was 36.62% (a -117.17% decrease from previous year)
  • Annual EPS Growth (diluted) for 2019 was -213.24% (a 470.62% increase from previous year)
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS Growth (diluted) of Atreca, Inc.

Most recent EPS Growth (diluted)of BCEL including historical data for past 10 years.

Interactive Chart of EPS Growth (diluted) of Atreca, Inc.

Atreca, Inc. EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 18.92% 0.0% 7.14%
2021 -25.4% -12.12% -1.41% 4.11% -9.26%
2020 12.5% -15.79% 80.65% -4.29% 36.62%
2019 -14.29% 13.64% -416.9% -213.24%
2018 -37.37%
2017 27.21%

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology